Pioglar-G 15+2mg 10 Tablets

Babies: It is not applicable. Lactating mother: It is safe during breastfeeding.
Limited human studies suggest that the drug does not represent a significant risk to the baby. Pregnancy: It is unsafe to use this medicine during pregnancy.
Limited human studies have shown harmful effects on the developing baby. Seek a doctor's advice before using this medication. Driving: Your ability to drive may be affected if your blood sugar is too low or too high.
Do not drive if these symptoms occur. Alcohol: Avoid consuming alcohol with glimepiride and pioglitazone hcl tablet. Seek a doctor's advice before using this medication. Kidney: Glimepiride and pioglitazone hcl tablet should use with caution in patients with kidney disease.
Dosage adjustment is needed. Seek a doctor's advice before using this medication. Liver: Glimepiride and pioglitazone hcl tablet should use with caution in patients with liver disease.
Dosage adjustment is needed. Seek doctor advice before using this medication.
These patients can experience low blood sugar levels that may become normal after a long time..

Nausea Headache Diarrhoea Edema Cold symptoms Leg pain Accidental injury.

PIOGLAR G tablet is a sulfonylurea and thiazolidinedione. pioglitazone works by increasing the body’s sensitivity to o insulin.
glimepiride works by increasing the amount of insulin released by the pancreas to lower blood glucose. It helps to control blood sugar levels..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Pioglar g tablet is a sulfonylurea and thiazolidinedione used to treat type 2 diabetes mellitus • Take this medication as per dose and duration prescribed by your doctor • It may cause hypoglycemia when used with other antidiabetic medicines, alcohol or if you delay • Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, and tremor • Inform your doctor if you notice weight gain, shortness of breath, irregular heartbeat, or any abnormal swelling • Your doctor may check your liver function regularly. Inform your doctor if you experience any symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin.

Serious • Glimepiride + Aminolevulinic acid oral: Concurrent use leads to increased toxicity of the other by pharmacodynamic synergism • Glimepiride + Aminolevulinic acid topical: Concurrent use leads to increased toxicity of aminolevulinic acid topical by pharmacodynamic synergism • Glimepiride + Ivosidenib: Concurrent use leads to a decrease in the level or effect of glimepiride by affecting hepatic enzyme cyp2c9/10 metabolism • Pioglitazone + Gemfibrozil: Concurrent use leads to a decrease in the level or effect of glimepiride by affecting hepatic enzyme cyp2c9/10 metabolism • Pioglitazone + Baricitinib: Concurrent use leads to an increase in the level or effect of pioglitazone by decreasing metabolism • Pioglitazone + Tucatinib: Concurrent use leads to an increase in the level or effect of tucatinib.